Creative Capital Management Investments LLC
Source: SEC Form 13F · as of Mar 2026Creative Capital Management Investments LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $1.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$1.9M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 3,916 | $546K |
| ABBVAbbVie Inc. | 1,461 | $318K |
| AMGNAMGEN INC | 629 | $221K |
| BMYBRISTOL MYERS SQUIBB CO | 3,127 | $190K |
| PFEPFIZER INC | 5,614 | $158K |
| MRKMerck & Co., Inc. | 1,113 | $134K |
| ABTABBOTT LABORATORIES | 824 | $85K |
| MCKMcKesson Corporation | 78 | $67K |
| JNJJOHNSON & JOHNSON | 258 | $63K |
| LLYELI LILLY & Co | 52 | $48K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 146 | $40K |
| ZBHZimmer Biomet Holdings Inc. | 253 | $23K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 24 | $11K |
| NVSNovartis AG | 59 | $9K |
| AZNASTRAZENECA PLC | 7 | $1K |
| AVNSAvanos Medical Inc. | 28 | $392 |
| GEHCGE HealthCare Technologies Inc. | 2 | $142 |
| AMRNAMARIN CORP PLCUK | 9 | $130 |
| VTRSViatris Inc | 3 | $41 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.